CU23460A1 - Composiciones vacunales obtenidas a partir de streptomyces - Google Patents
Composiciones vacunales obtenidas a partir de streptomycesInfo
- Publication number
- CU23460A1 CU23460A1 CU20040051A CU20040051A CU23460A1 CU 23460 A1 CU23460 A1 CU 23460A1 CU 20040051 A CU20040051 A CU 20040051A CU 20040051 A CU20040051 A CU 20040051A CU 23460 A1 CU23460 A1 CU 23460A1
- Authority
- CU
- Cuba
- Prior art keywords
- streptomyces
- vaccine compositions
- compositions obtained
- strains
- specifically
- Prior art date
Links
- 241000187747 Streptomyces Species 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 abstract 1
- 208000035473 Communicable disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 241000187398 Streptomyces lividans Species 0.000 abstract 1
- 241000187180 Streptomyces sp. Species 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000000172 allergic effect Effects 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000002458 infectious effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se relaciona con el campo de la inmunología, específicamente con composiciones vacunales a partir de Streptomyces para la prevención de enfermedades infecciosas, tumorales, alérgicas y autoinmunes. Las composiciones vacunales comprenden una o más cepas salvajes del género Streptomyces o cepas mutantes o recombinantes expresando antígenos heterólogos derivados de las mismas, específicamente pueden emplearse cepas vivas de Streptomyces lividans, Sterptomyces coelicolor y Streptomyces Sp.
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20040051A CU23460A1 (es) | 2004-03-18 | 2004-03-18 | Composiciones vacunales obtenidas a partir de streptomyces |
EP05729588A EP1743651B1 (en) | 2004-03-18 | 2005-03-18 | Vaccine compositions which are obtained from streptomyces |
JP2007503180A JP4875606B2 (ja) | 2004-03-18 | 2005-03-18 | ストレプトミセスから得られたワクチン組成物 |
CNA2005800130466A CN1960751A (zh) | 2004-03-18 | 2005-03-18 | 由链霉菌获得的疫苗组合物 |
CA2559633A CA2559633C (en) | 2004-03-18 | 2005-03-18 | Vaccine compositions obtained from streptomyces |
RU2006136806/15A RU2006136806A (ru) | 2004-03-18 | 2005-03-18 | Композиции вакцин, полученные из streptomyces |
ES05729588T ES2323080T3 (es) | 2004-03-18 | 2005-03-18 | Composiciones vacunales obtenidas a partir de streptomyces. |
KR1020067021156A KR20070026454A (ko) | 2004-03-18 | 2005-03-18 | 스트렙토미세스로부터 얻어진 백신 조성물 |
AT05729588T ATE419868T1 (de) | 2004-03-18 | 2005-03-18 | Vakzine-zusammensetzungen aus streptomyces |
DE602005012252T DE602005012252D1 (de) | 2004-03-18 | 2005-03-18 | Vakzine-zusammensetzungen aus streptomyces |
PCT/CU2005/000002 WO2005087259A1 (es) | 2004-03-18 | 2005-03-18 | Composiciones vacunales obtenidas a partir de streptomyces. |
BRPI0508160-2A BRPI0508160A (pt) | 2004-03-18 | 2005-03-18 | composições de vacina obtidas a partir de streptomyces |
US10/593,225 US20070292452A1 (en) | 2004-03-18 | 2005-03-18 | Vaccine Compositions Which Are Obtained From Streptomyces |
MXPA06010616A MXPA06010616A (es) | 2004-03-18 | 2005-03-18 | Composiciones vacunales obtenidas a partir de streptomyces. |
AU2005221262A AU2005221262A1 (en) | 2004-03-18 | 2005-03-18 | Vaccine compositions which are obtained from Streptomyces |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20040051A CU23460A1 (es) | 2004-03-18 | 2004-03-18 | Composiciones vacunales obtenidas a partir de streptomyces |
Publications (1)
Publication Number | Publication Date |
---|---|
CU23460A1 true CU23460A1 (es) | 2009-12-01 |
Family
ID=40251560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20040051A CU23460A1 (es) | 2004-03-18 | 2004-03-18 | Composiciones vacunales obtenidas a partir de streptomyces |
Country Status (15)
Country | Link |
---|---|
US (1) | US20070292452A1 (es) |
EP (1) | EP1743651B1 (es) |
JP (1) | JP4875606B2 (es) |
KR (1) | KR20070026454A (es) |
CN (1) | CN1960751A (es) |
AT (1) | ATE419868T1 (es) |
AU (1) | AU2005221262A1 (es) |
BR (1) | BRPI0508160A (es) |
CA (1) | CA2559633C (es) |
CU (1) | CU23460A1 (es) |
DE (1) | DE602005012252D1 (es) |
ES (1) | ES2323080T3 (es) |
MX (1) | MXPA06010616A (es) |
RU (1) | RU2006136806A (es) |
WO (1) | WO2005087259A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102100431B1 (ko) * | 2018-09-11 | 2020-04-13 | 한국해양과학기술원 | 스트렙토미세스로부터 유래된 새로운 화합물 및 용도 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8315579D0 (en) * | 1983-06-07 | 1983-07-13 | Biogen Nv | Streptomyces expression systems |
US6537558B2 (en) * | 1997-03-31 | 2003-03-25 | Megan Health, Inc. | Methods of producing and using virulence attenuated poxR mutant bacteria |
EP0962532A1 (en) * | 1998-06-03 | 1999-12-08 | Innogenetics N.V. | Polypeptides and nucleic acids encoding the same for the diagnosis and prevention of tuberculosis disease. |
WO2003051288A2 (en) * | 2001-11-14 | 2003-06-26 | Novavax, Inc. | Mycobacterial vaccine |
KR100474111B1 (ko) * | 2001-12-26 | 2005-03-10 | 한국생명공학연구원 | 스트렙토마이세스 속 amlk-335 균주 및 그 생산화합물의 용도 |
-
2004
- 2004-03-18 CU CU20040051A patent/CU23460A1/es unknown
-
2005
- 2005-03-18 ES ES05729588T patent/ES2323080T3/es active Active
- 2005-03-18 WO PCT/CU2005/000002 patent/WO2005087259A1/es active Search and Examination
- 2005-03-18 US US10/593,225 patent/US20070292452A1/en not_active Abandoned
- 2005-03-18 RU RU2006136806/15A patent/RU2006136806A/ru not_active Application Discontinuation
- 2005-03-18 AT AT05729588T patent/ATE419868T1/de not_active IP Right Cessation
- 2005-03-18 CN CNA2005800130466A patent/CN1960751A/zh active Pending
- 2005-03-18 DE DE602005012252T patent/DE602005012252D1/de active Active
- 2005-03-18 BR BRPI0508160-2A patent/BRPI0508160A/pt not_active IP Right Cessation
- 2005-03-18 AU AU2005221262A patent/AU2005221262A1/en not_active Abandoned
- 2005-03-18 CA CA2559633A patent/CA2559633C/en not_active Expired - Fee Related
- 2005-03-18 EP EP05729588A patent/EP1743651B1/en not_active Not-in-force
- 2005-03-18 KR KR1020067021156A patent/KR20070026454A/ko not_active Application Discontinuation
- 2005-03-18 JP JP2007503180A patent/JP4875606B2/ja not_active Expired - Fee Related
- 2005-03-18 MX MXPA06010616A patent/MXPA06010616A/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN1960751A (zh) | 2007-05-09 |
ES2323080T3 (es) | 2009-07-06 |
US20070292452A1 (en) | 2007-12-20 |
AU2005221262A1 (en) | 2005-09-22 |
BRPI0508160A (pt) | 2007-08-07 |
EP1743651B1 (en) | 2009-01-07 |
MXPA06010616A (es) | 2007-07-04 |
EP1743651A1 (en) | 2007-01-17 |
DE602005012252D1 (de) | 2009-02-26 |
WO2005087259A1 (es) | 2005-09-22 |
CA2559633A1 (en) | 2005-09-22 |
KR20070026454A (ko) | 2007-03-08 |
JP4875606B2 (ja) | 2012-02-15 |
ATE419868T1 (de) | 2009-01-15 |
JP2007529432A (ja) | 2007-10-25 |
CA2559633C (en) | 2011-09-06 |
RU2006136806A (ru) | 2008-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12019501557A1 (en) | Bacillus isolates and uses thereof | |
CO2017013287A2 (es) | Composiciones que comprenden una cepa bacteriana del género roseburia | |
CO2017013231A2 (es) | Composiciones que comprenden una cepa bacteriana del género parabacteroides | |
EP4218807A3 (en) | Zika virus vaccine | |
WO2016007576A8 (en) | Novel vaccine compositions for porcine epidemic diarrhea virus and porcine deltacoronavirus | |
EA201790109A1 (ru) | Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки | |
WO2007095318A3 (en) | Influenza antigens, vaccine compositions, and related methods | |
BR112018071198A2 (pt) | métodos para melhorar a produção agrícola de aves pela administração de consórcios microbianos ou de cepas purificadas dos mesmos | |
AR058983A1 (es) | Metodos y composiciones para el tratamiento de enfermedades alergicas | |
EA201500857A1 (ru) | Комбинированные вакцины с синтетическими наноносителями | |
PE20181176A1 (es) | Composiciones biofarmaceuticas | |
EA201791416A1 (ru) | Популяции клеток rpe и способы их получения | |
UY32457A (es) | Vacuna del virus del dengue inactivado | |
PH12018000197A1 (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
WO2008134643A3 (en) | Trypanosoma antigens, vaccine compositions, and related methods | |
ECSP077179A (es) | Co-cultivos manejados de organismos que tienen efectos profilacticos y promotores de la salud | |
WO2014205199A3 (en) | Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency | |
ECSP23025065A (es) | Anticuerpos de cadena pesada multiespecíficos con regiones constantes de cadena pesada modificadas | |
MX2019005040A (es) | Métodos y composiciones para prevenir la transmisión de enfermedades vectoriales. | |
MX2021000776A (es) | Usos de composiciones de curcuminoides. | |
CU23460A1 (es) | Composiciones vacunales obtenidas a partir de streptomyces | |
BR112022020298A2 (pt) | Vacinas, adjuvantes e métodos para gerar uma resposta imune | |
AR060182A1 (es) | Polisacaridos capsulares tipo 5 y tipo 8 de cepas s. aureus de sobreproduccion | |
MX2018012832A (es) | Composiciones que comprenden 2-sec-butil-4,5-dihidrotiazol o 3,4-deshidro-exo-brevicomina como atrayentes para ratones. | |
CA3156472A1 (en) | POLYMER COMPOSITION |